Cargando…
Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288312/ https://www.ncbi.nlm.nih.gov/pubmed/25746013 http://dx.doi.org/10.1186/2051-1426-2-S3-O1 |
| _version_ | 1782351944090648576 |
|---|---|
| author | Johnson, Laura A Scholler, John Ohkuri, Takayuki Kosaka, Akemi Patel, Prachi R McGettigan, Shannon E Nace, Arben Thekkat, Pramod Loew, Andreas Chen, Taylor J Fraietta, Joseph A Posey, Avery D Boesteanu, Alina C Cogdill, Alexandria P Engels, Boris Singh, Reshma Ezell, Tucker R Idamakanti, Neeraja Plesa, Gabriela Seykora, John Okada, Hideho June, Carl Brogdon, Jennifer Maus, Marcela |
| author_facet | Johnson, Laura A Scholler, John Ohkuri, Takayuki Kosaka, Akemi Patel, Prachi R McGettigan, Shannon E Nace, Arben Thekkat, Pramod Loew, Andreas Chen, Taylor J Fraietta, Joseph A Posey, Avery D Boesteanu, Alina C Cogdill, Alexandria P Engels, Boris Singh, Reshma Ezell, Tucker R Idamakanti, Neeraja Plesa, Gabriela Seykora, John Okada, Hideho June, Carl Brogdon, Jennifer Maus, Marcela |
| author_sort | Johnson, Laura A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288312 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42883122015-01-15 Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma Johnson, Laura A Scholler, John Ohkuri, Takayuki Kosaka, Akemi Patel, Prachi R McGettigan, Shannon E Nace, Arben Thekkat, Pramod Loew, Andreas Chen, Taylor J Fraietta, Joseph A Posey, Avery D Boesteanu, Alina C Cogdill, Alexandria P Engels, Boris Singh, Reshma Ezell, Tucker R Idamakanti, Neeraja Plesa, Gabriela Seykora, John Okada, Hideho June, Carl Brogdon, Jennifer Maus, Marcela J Immunother Cancer Oral Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288312/ /pubmed/25746013 http://dx.doi.org/10.1186/2051-1426-2-S3-O1 Text en Copyright © 2014 Johnson et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Johnson, Laura A Scholler, John Ohkuri, Takayuki Kosaka, Akemi Patel, Prachi R McGettigan, Shannon E Nace, Arben Thekkat, Pramod Loew, Andreas Chen, Taylor J Fraietta, Joseph A Posey, Avery D Boesteanu, Alina C Cogdill, Alexandria P Engels, Boris Singh, Reshma Ezell, Tucker R Idamakanti, Neeraja Plesa, Gabriela Seykora, John Okada, Hideho June, Carl Brogdon, Jennifer Maus, Marcela Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma |
| title | Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma |
| title_full | Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma |
| title_fullStr | Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma |
| title_full_unstemmed | Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma |
| title_short | Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma |
| title_sort | pre-clinical validation of a humanized anti-egfr variant iii chimeric antigen receptor and phase i trial of cart-egfrviii in glioblastoma |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288312/ https://www.ncbi.nlm.nih.gov/pubmed/25746013 http://dx.doi.org/10.1186/2051-1426-2-S3-O1 |
| work_keys_str_mv | AT johnsonlauraa preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT schollerjohn preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT ohkuritakayuki preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT kosakaakemi preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT patelprachir preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT mcgettiganshannone preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT nacearben preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT thekkatpramod preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT loewandreas preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT chentaylorj preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT fraiettajosepha preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT poseyaveryd preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT boesteanualinac preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT cogdillalexandriap preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT engelsboris preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT singhreshma preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT ezelltuckerr preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT idamakantineeraja preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT plesagabriela preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT seykorajohn preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT okadahideho preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT junecarl preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT brogdonjennifer preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma AT mausmarcela preclinicalvalidationofahumanizedantiegfrvariantiiichimericantigenreceptorandphaseitrialofcartegfrviiiinglioblastoma |